The Alliance

Statement on State of the Union Address

February 6, 2019 9:11 am

Washington, DC—The Alliance to Protect Medical Innovation’s Executive Director Patrick O’Connor released the following statement on the president’s State of the Union Address:


“As President Trump noted in his speech, the price of prescription drugs has slowed dramatically in recent years, a fact often overlooked by politicians and the media. Any effort to control healthcare costs should preserve the unique ecosystem that drastically reduced AIDS deaths in the U.S. and offers the promise of future breakthroughs to treat childhood cancer.”


The Alliance to Protect Medical Innovation is a nonpartisan group committed to fostering a national conversation on medical innovation and patient access to care that is holistic and fact-based. The Alliance evaluates policy proposals and fact-checks claims affecting biomedical innovation, as well as responds to attacks on this innovation ecosystem. We are committed to preserving the pipeline of breakthrough medicines that reduce costs within the health care system and help people live longer, healthier and more productive lives. The Alliance receives funding from biopharmaceutical companies and other entities that represent the industry.